Histopathology Scoring and SARS-CoV-2 Antigen Detection
Corresponding Organization :
Other organizations : University of Hong Kong, Hong Kong Science and Technology Parks Corporation, BGI Group (China), Queen Mary Hospital, Hainan Medical University, University of Hong Kong - Shenzhen Hospital
Variable analysis
- Haematoxylin and Eosin (H&E) staining of formalin-fixed and paraffin-embedding tissue sections (4 μm each)
- ACE2 recombinant rabbit monoclonal antibody (MA5-32307, Invitrogen)
- In-house antibody of rabbit anti SARS-CoV-2 nucleocapsid protein (NP)
- FITC–conjugated goat anti rabbit IgG (65-6111, Thermo Fisher Scientific, Waltham, MA, USA)
- Histopathology changes in lungs
- Severity of histopathology in lungs scored 0-4
- ACE2 protein expression detected by haematoxylin
- SARS-CoV-2 nucleocapsid protein (NP) expression scored 0-4 in lung and nasal turbinate (NT) tissues
- Complete masking during assessment of histopathology severity
- Mounting the tissue sections with the VectaMount permanent mounting medium (Vector Laboratories)
- Not explicitly mentioned
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!